The recent study also demonstrated that cancer cells relying on more OPXHOS are highly expressing DNMT1 and lowly expressing NNMT, by genetically manipulating the expression of NNMT and DNMT1, the sensitivity to OXPHOS inhibitors are changed 61. Here, DNMT1 is linked to cancer.